Free Trial
NASDAQ:MOVE

Movano Q4 2024 Earnings Report

Movano logo
$16.70 -0.55 (-3.19%)
Closing price 04:00 PM Eastern
Extended Trading
$16.73 +0.03 (+0.15%)
As of 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Movano EPS Results

Actual EPS
-$6.10
Consensus EPS
-$9.70
Beat/Miss
Beat by +$3.60
One Year Ago EPS
N/A

Movano Revenue Results

Actual Revenue
$0.11 million
Expected Revenue
$1.50 million
Beat/Miss
Missed by -$1.39 million
YoY Revenue Growth
N/A

Movano Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
Wednesday, April 9, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Movano's Q2 2026 earnings is estimated for Thursday, August 13, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, August 18, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Movano Earnings Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
See More Movano Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Movano? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Movano and other key companies, straight to your email.

About Movano

Movano (NASDAQ:MOVE) Health, Inc. (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality. The ring communicates wirelessly with a companion mobile application, where users can view detailed daily reports, set personalized health goals, and share data securely with healthcare providers or loved ones. By combining hardware design with cloud-based analytics, Movano aims to deliver actionable insights that support preventive care and early intervention.

To advance its platform, Movano collaborates with academic institutions, clinical researchers and technology partners. These collaborations help validate sensor accuracy, refine algorithms and explore new applications in areas such as women’s health, chronic disease management and fitness optimization. The company’s development roadmap includes pursuing regulatory clearances and expanding integrations with electronic health record systems.

Led by a management team with combined expertise in medical devices, consumer electronics and software development, Movano serves customers primarily in North America and is exploring opportunities for expansion into international markets. The company continues to invest in research and development to enhance its sensor suite and broaden its suite of health-monitoring solutions for both consumers and healthcare professionals.

View Movano Profile